| |
| |
|
| Insider
Information: |
Brown Bob |
| Relationship: |
Chief Scientific Ofr.,... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dicerna Pharmaceuticals Inc |
DRNA |
Chief Scientific Ofr.,... |
2021-12-28 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Officer, SVPO |
• – – |
2014-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,339 |
|
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2021-01-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,650 |
35,167 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,775 |
4,042 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2019-12-30 |
4 |
OE |
$2.97 |
$42,697 |
D/D |
13,136 |
22,806 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2019-12-31 |
4 |
OE |
$2.97 |
$52,565 |
D/D |
16,941 |
16,941 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-04-20 |
4 |
OE |
$2.97 |
$39,445 |
D/D |
13,281 |
18,281 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-05-11 |
4 |
OE |
$2.97 |
$39,445 |
D/D |
13,281 |
18,281 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-06-19 |
4 |
OE |
$2.97 |
$28,720 |
D/D |
9,670 |
14,670 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-02-10 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
13,185 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-03-02 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
13,185 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-04-17 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
13,185 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-05-05 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
13,185 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-06-01 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
13,185 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-07-01 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
13,185 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-08-03 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
13,185 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-09-14 |
4 |
OE |
$3.42 |
$913 |
D/D |
267 |
5,267 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-09-16 |
4 |
OE |
$3.42 |
$72,675 |
D/D |
21,250 |
26,517 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-10-16 |
4 |
OE |
$3.42 |
$55,985 |
D/D |
16,370 |
42,887 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-11-02 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
34,702 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
See Remarks |
• – – |
2020-12-01 |
4 |
OE |
$3.42 |
$27,993 |
D/D |
8,185 |
34,702 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-05-03 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-06-01 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-07-01 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-08-02 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-01-25 |
4 |
OE |
$9.09 |
$151,167 |
D/D |
16,630 |
43,147 |
0 |
- |
|
63 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
